Biomdrin SRL
Biomdrin reported total assets of 38,268 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Biomdrin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biomdrin's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
Biomdrin's financial analysis
- Solvency58.3%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biomdrin
Biomdrin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1004.523.585
- VAT number
- BE1004523585
- Peppol
- Registered · 0208:1004523585 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Jan 2024
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Biomdrin (SRL) has been based in Schilde since 2024, active in: manufacture of medicaments. For 2025, it reports a net profit of 2,799 € and equity of 22,328 €; its revenue is not published. Its solvency stands at 58.3%, above the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biomdrin
Companies in the same business, of comparable size and area, outside its group.
- MC Pharma Manufacture of basic pharmaceutical products Beaumont · balance sheet 28,699 €
- Estrella Clinical Research Manufacture of basic pharmaceutical products Herentals · balance sheet 41,482 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Inchinn Therapeutics Manufacture of basic pharmaceutical products Charleroi · balance sheet 51,394 €
- OncoRNA Research and experimental development on natural sciences and engineering Charleroi · balance sheet 20,034 €
- Attito Management Manufacture of pharmaceutical preparations Kapelle-op-den-Bos · balance sheet 131,498 €
- Mythralica Manufacture of pharmaceutical preparations Etterbeek · balance sheet 135,553 €
- Intibio Manufacture of pharmaceutical preparations Bree · balance sheet 407,778 €
Frequently asked questions about Biomdrin
What is the revenue of Biomdrin?
Biomdrin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biomdrin?
In Belgium, the VAT number is the company number prefixed with BE: BE1004523585 for Biomdrin, if the company is VAT-registered. Its company number (CBE) is 1004.523.585.
Where is the registered office of Biomdrin?
According to the CBE register, the registered office of Biomdrin is in 2970 Schilde.
What is the equity of Biomdrin?
At the close of the 2025 financial year, the equity of Biomdrin amounts to 22,328 €, a solvency of 58.3% of total assets.
Who manages Biomdrin?
The register lists 3 active mandates at Biomdrin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biomdrin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →